All subcategories » published RCT
Pharmacokinetics and safety of tobramycin administered by the PARI eFlow rapid nebulizer in cystic fibrosis.
primary studies published RCT
Details- 2009
- Hubert D
Continuous versus intermittent infusions of ceftazidime for treating exacerbation of cystic fibrosis.
primary studies published RCT
Details- 2009
- Hubert D
Bioavailability of oral vitamin E formulations in adult volunteers and children with chronic cholestasis or cystic fibrosis.
primary studies published RCT
Details- 2009
- Jacquemin E
Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light.
primary studies published RCT
Details- 2009
- Khazai NB
Cystic fibrosis: are volumetric ultra-low-dose expiratory CT scans sufficient for monitoring related lung disease?.
primary studies published RCT
Details- 2009
- Loeve M
Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial.
primary studies published RCT
Details- 2009
- Moran A
One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements.
primary studies published RCT
Details- 2009
- Mozzillo E
Pancreatic enzyme replacement therapy for young cystic fibrosis patients.
primary studies published RCT
Details- 2009
- Munck A
Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis.
primary studies published RCT
Details- 2009
- Retsch-Bogart GZ
Tobramycin once- vs thrice-daily for elective intravenous antipseudomonal therapy in pediatric cystic fibrosis patients.
primary studies published RCT
Details- 2009
- Riethmueller J